From Lab to Patient- Commercialization Pathways and Regulatory Navigation in Biopharma

From Lab to Patient -- Commericialization Pathways and Regulatory Navigation in Biopharma

Professor Robert Brunner explores the profound impact of emerging technologies on society with a special focus on the disruption caused by advancements in artificial intelligence (AI). It aims to equip students with a deep understanding of how these technologies are reshaping the landscape of various industries, the economy, and societal norms at large.